Lixisenatide H3 H4(1-22) is a synthetic peptide

H4(1-22) is a synthetic peptide corresponding to the first 22 amino acids of the histone H4 protein

allowing the incorporation of histidine residues with protected side chains

with acetylation at lysine 16 and a biotin conjugation

This peptide is key for exploring the role of specific histone methylations and for modification studies

FRET substrate Abz‐VAD‐norV‐ADRQ‐EDDnp

Lixisenatide H3 H4(1-22) is a synthetic peptideLixisenatide, 44 amino acid GLP 1 receptor agonist. Sequence HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK NH2. Synthesised by our ISO 9001 certified UK laboratory. Strictly for research use only. Not for therapeutic or clinical applications in humans or animals.